摘要
背景:热疗(HT)在肿瘤治疗中得到了广泛的应用,现代设备的发展使其更加高效。紫草素是从中草药中提取的天然萘醌衍生物。虽然SHK的抗癌作用是明显的,但其潜在的分子机制尚不完全清楚。目的:观察小剂量SHK联合轻度HT对U 937细胞的作用。方法:44°C高温处理10 min,观察细胞凋亡、活性氧生成和细胞内钙升高的变化,采用DNA片段化、流式细胞术和westernblot分析。结果:Shk 0.5μM能明显增强HT诱导的细胞凋亡,表现为DNA片段化和caspase-3活性增加,ROS生成增加,细胞内钙升高。联合治疗还能协同激活促凋亡蛋白和灭活的抗凋亡蛋白.此外,JNK和PKC-δ的磷酸化以及ERK和AKT的去磷酸化是可能复合诱导细胞凋亡的上游效应。NAC和JNK-IN-8通过阻断MAPK通路和caspase-3的切割,使HT和SHK的调节作用消失。细胞内钙也升高,并被发现与诱导细胞死亡明显的DNA片段,无论是否使用BAPTA-AM。结论:本研究为SHK联合HT治疗肿瘤细胞凋亡提供了有说服力的证据,为肿瘤的治疗提供了一种新的策略。
关键词: 热疗,紫草素,癌症,凋亡,JNK,PKC-δ,Ca2+.
Current Molecular Medicine
Title:Excessive Oxidative Stress in the Synergistic Effects of Shikonin on the Hyperthermia-Induced Apoptosis
Volume: 18 Issue: 5
关键词: 热疗,紫草素,癌症,凋亡,JNK,PKC-δ,Ca2+.
摘要: Background: Hyperthermia (HT) has been used widely for cancer therapy, and the development of modern devices has made it more efficient. Shikonin (SHK) is a natural naphthoquinone derivative from a Chinese herb. Although the anticancer properties of SHK are evident, the underlying molecular mechanisms are not fully understood.
Objective: In this study, the effects of combining low doses of SHK with mild HT were investigated in the U937 cell line.
Methods: The cells were subjected to HT at 44°C for 10 min with or without SHK pretreatment, and parameters reflecting apoptosis, ROS generation and intracellular calcium elevation were evaluated by using DNA fragmentation, flow cytometry, and western blot analyses.
Results: SHK 0.5 µM significantly enhanced HT-induced apoptosis as indicated by DNA fragmentation and caspase-3 activation with increased generation of ROS and elevation of intracellular calcium. The combined treatment also synergistically activated proapoptotic proteins and inactivated anti-apoptotic proteins. Furthermore, the phosphorylation of JNK and PKC- δ and the dephosphorylation of ERK and AKT were the upstream effects that may have compounded the induction of apoptosis. The modulatory effects of HT and SHK were abrogated with the employment of NAC and JNK-IN-8 by inactivating the MAPK pathway and cleavage of caspase-3. Intracellular calcium was also elevated and was found to be responsible for the induction of cell death evident by the DNA fragmentation with or without the employment of BAPTA-AM.
Conclusion: Conclusively, this study provides persuasive evidence that SHK in combination with HT is a propitious therapeutic way for augmentation of apoptosis and hence suggest a novel strategy for treating cancers.
Export Options
About this article
Cite this article as:
Excessive Oxidative Stress in the Synergistic Effects of Shikonin on the Hyperthermia-Induced Apoptosis, Current Molecular Medicine 2018; 18 (5) . https://dx.doi.org/10.2174/1566524018666181024161704
DOI https://dx.doi.org/10.2174/1566524018666181024161704 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance
Current Cancer Drug Targets Curcumin: A Natural Product for Diabetes and its Complications
Current Topics in Medicinal Chemistry Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects
Current Cancer Drug Targets Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase
Current Drug Targets Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes
Current Signal Transduction Therapy Advances in Tumor Targeted Liposomes
Current Molecular Medicine Toll-Like Receptors in Alzheimer's Disease: A Therapeutic Perspective
CNS & Neurological Disorders - Drug Targets Epigenetic Mismatches with Mutated Transcribing Genes at Leukemogenic S-Phase Binding/Start Sites – Potential Targets for Therapy with Enzyme Inhibitors
Current Stem Cell Research & Therapy Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy
Current Pharmaceutical Design Therapeutic Targeting of Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Antioxidant Supplements, Genetics and Chemotherapy Outcomes
Current Cancer Therapy Reviews Double-Edged Sword of Novel Anti-Cancer Treatment: Proteasome Inhibition in the Growth Plate Causes Impairment of Longitudinal Bone Growth
Current Pediatric Reviews Current Treatment of Psoriasis with Biologics
Current Drug Discovery Technologies Use of Peripheral Blood Stem Cells in Tissue Engineering
Current Tissue Engineering (Discontinued) Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets The Structure and Pharmacological Functions of Coumarins and Their Derivatives
Current Medicinal Chemistry Culture Supernatants from Lactobacillus plantarum Induce Necrosis on a Human Promyelocytic Leukemia Cell Line
Endocrine, Metabolic & Immune Disorders - Drug Targets The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Current Respiratory Medicine Reviews Multiple Sclerosis – Established and Novel Therapeutic Approaches
Central Nervous System Agents in Medicinal Chemistry